KRS Capital Management »

SPDR S&P Biotech shares owned by KRS Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by KRS Capital Management from 13F filings

Historical chart of KRS Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by KRS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by KRS Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $241k 2.5k 94.90
2023-12-31 $224k 2.5k 89.30
2023-06-30 $228k 2.7k 83.21
2022-12-31 $210k 2.5k 83.01
2021-12-31 $62k 560 110.71

More positions owned by KRS Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Fortinet (FTNT)
Meta Platforms Cl A (META)
Palo Alto Networks (PANW)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Qualcomm (QCOM)
Alphabet Cap Stk Cl A (GOOGL)
salesforce (CRM)
Abbvie (ABBV)
Honeywell International (HON)
JPMorgan Chase & Co. (JPM)

View all positions for KRS Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities
Brown Advisory Holdings Incorporated

View all funds holding SPDR S&P Biotech